Control of disease tolerance to malaria by nitric oxide and carbon monoxide

Cell Reports

Volumn 8, Issue 1, 2014, Pages 126-136

  Jeney, Viktória ^a,d   Ramos, Susana ^a   Bergman, Marie Louise ^a   Bechmann, Ingo ^b   Tischer, Jasmin ^b   Ferreira, Ana ^a,e   Oliveira Marques, Virginia ^a   Janse, Chris J ^c   Rebelo, Sofia ^a   Cardoso, Silvia ^a   Soares, Miguel P ^a  

^a INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^b Institute of Anatomy   (Germany)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF DEBRECEN   (Hungary)

^e UNIVERSIDADE NOVA DE LISBOA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; HEME OXYGENASE 1; NITRIC OXIDE; TRANSCRIPTION FACTOR NRF2; HEME; NFE2L2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CATABOLISM; CD4+ T HELPER CELL; CD8+ CYTOTOXIC T CELL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG BIOAVAILABILITY; ENZYME INDUCTION; EXPERIMENTAL CEREBRAL MALARIA; GENE EXPRESSION; HELPER CELL; IMMUNOMODULATION; MALARIA; MALARIA CONTROL; MOUSE; NONHUMAN; PATHOGEN LOAD; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; BRAIN MALARIA; BRAIN PROTECTION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DISEASE SEVERITY; IMMUNOLOGICAL TOLERANCE; INFECTION CONTROL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; DRUG EFFECTS; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALARIA, CEREBRAL; METABOLISM;

MUS;

ANIMALS; CARBON MONOXIDE; CD8-POSITIVE T-LYMPHOCYTES; HEME OXYGENASE-1; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; MALARIA, CEREBRAL; MICE; MICE, INBRED C57BL; NF-E2-RELATED FACTOR 2; NITRIC OXIDE; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84904043019     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.05.054     Document Type: Article

References (62)

1. Andrade B.B., Araújo-Santos T., Luz N.F., Khouri R., Bozza M.T., Camargo L.M., Barral A., Borges V.M., Barral-Netto M. Heme impairs prostaglandin E2 and TGF-beta production by human mononuclear cells via Cu/Zn superoxide dismutase: insight into the pathogenesis of severe malaria. J.Immunol. 2010, 185:1196-1204.
2. Anstey N.M., Weinberg J.B., Hassanali M.Y., Mwaikambo E.D., Manyenga D., Misukonis M.A., Arnelle D.R., Hollis D., McDonald M.I., Granger D.L. Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J.Exp. Med. 1996, 184:557-567.
3. Ayres J.S., Schneider D.S. Tolerance of infections. Annu. Rev. Immunol. 2012, 30:271-294.
4. Balla J., Jacob H.S., Balla G., Nath K., Eaton J.W., Vercellotti G.M. Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. Proc. Natl. Acad. Sci. USA 1993, 90:9285-9289.
5. Belcher J.D., Chen C., Nguyen J., Milbauer L., Abdulla F., Alayash A.I., Smith A., Nath K.A., Hebbel R.P., Vercellotti G.M. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. Blood 2014, 123:377-390.
6. Belnoue E., Kayibanda M., Vigario A.M., Deschemin J.C., van Rooijen N., Viguier M., Snounou G., Rénia L. On the pathogenic role of brain-sequestered alphabeta CD8+ Tcells in experimental cerebral malaria. J.Immunol. 2002, 169:6369-6375.
7. Belnoue E., Potter S.M., Rosa D.S., Mauduit M., Grüner A.C., Kayibanda M., Mitchell A.J., Hunt N.H., Rénia L. Control of pathogenic CD8+ Tcell migration to the brain by IFN-gamma during experimental cerebral malaria. Parasite Immunol. 2008, 30:544-553.
8. Brito C., Naviliat M., Tiscornia A.C., Vuillier F., Gualco G., Dighiero G., Radi R., Cayota A.M. Peroxynitrite inhibits T lymphocyte activation and proliferation by promoting impairment of tyrosine phosphorylation and peroxynitrite-driven apoptotic death. J.Immunol. 1999, 162:3356-3366.
9. Bunn H.F., Jandl J.H. Exchange of heme among hemoglobins and between hemoglobin and albumin. J.Biol. Chem. 1968, 243:465-475.
10. Cabrales P., Zanini G.M., Meays D., Frangos J.A., Carvalho L.J. Nitric oxide protection against murine cerebral malaria is associated with improved cerebral microcirculatory physiology. J.Infect. Dis. 2011, 203:1454-1463.
11. Campanella G.S., Tager A.M., El Khoury J.K., Thomas S.Y., Abrazinski T.A., Manice L.A., Colvin R.A., Luster A.D. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Proc. Natl. Acad. Sci. USA 2008, 105:4814-4819.
12. Dhangadamajhi G., Mohapatra B.N., Kar S.K., Ranjit M. Genetic variation in neuronal nitric oxide synthase (nNOS) gene and susceptibility to cerebral malaria in Indian adults. Infect. Genet. Evol. 2009, 9:908-911.
13. Dhangadamajhi G., Mohapatra B.N., Kar S.K., Ranjit M.R. A new allele (eNOS4e) in the intron 4 (VNTR) of eNOS gene in malaria infected individuals of the population of Orissa (an eastern Indian state). Nitric Oxide 2010, 22:58-59.
14. Ferreira A., Balla J., Jeney V., Balla G., Soares M.P. A central role for free heme in the pathogenesis of severe malaria: the missing link?. J.Mol. Med. 2008, 86:1097-1111.
15. Ferreira A., Marguti I., Bechmann I., Jeney V., Chora A., Palha N.R., Rebelo S., Henri A., Beuzard Y., Soares M.P. Sickle hemoglobin confers tolerance to Plasmodium infection. Cell 2011, 145:398-409.
16. Figueiredo R.T., Fernandez P.L., Mourao-Sa D.S., Porto B.N., Dutra F.F., Alves L.S., Oliveira M.F., Oliveira P.L., Graça-Souza A.V., Bozza M.T. Characterization of heme as activator of Toll-like receptor 4. J.Biol. Chem. 2007, 282:20221-20229.
17. Francis S.E., Sullivan D.J., Goldberg D.E. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu. Rev. Microbiol. 1997, 51:97-123.
18. Franke-Fayard B., Trueman H., Ramesar J., Mendoza J., van der Keur M., van der Linden R., Sinden R.E., Waters A.P., Janse C.J. A Plasmodium berghei reference line that constitutively expresses GFP at a high level throughout the complete life cycle. Mol. Biochem. Parasitol. 2004, 137:23-33.
19. Gladwin M.T., Crawford J.H., Patel R.P. The biochemistry of nitric oxide, nitrite, and hemoglobin: role in blood flow regulation. Free Radic. Biol. Med. 2004, 36:707-717.
20. Gozzelino R., Soares M.P. Coupling heme and iron metabolism via ferritin H chain. Antioxid. Redox Signal. 2014, 20:1754-1769.
21. Gozzelino R., Jeney V., Soares M.P. Mechanisms of cell protection by heme oxygenase-1. Annu. Rev. Pharmacol. Toxicol. 2010, 50:323-354.
22. Gozzelino R., Andrade B.B., Larsen R., Luz N.F., Vanoaica L., Seixas E., Coutinho A., Cardoso S., Rebelo S., Poli M., et al. Metabolic adaptation to tissue iron overload confers tolerance to malaria. Cell Host Microbe 2012, 12:693-704.
23. Gramaglia I., Sobolewski P., Meays D., Contreras R., Nolan J.P., Frangos J.A., Intaglietta M., van der Heyde H.C. Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria. Nat. Med. 2006, 12:1417-1422.
24. Haque A., Best S.E., Unosson K., Amante F.H., de Labastida F., Anstey N.M., Karupiah G., Smyth M.J., Heath W.R., Engwerda C.R. Granzyme B expression by CD8+ Tcells is required for the development of experimental cerebral malaria. J.Immunol. 2011, 186:6148-6156.
25. Hawkes M., Opoka R.O., Namasopo S., Miller C., Thorpe K.E., Lavery J.V., Conroy A.L., Liles W.C., John C.C., Kain K.C. Inhaled nitric oxide for the adjunctive therapy of severe malaria: protocol for a randomized controlled trial. Trials 2011, 12:176.
26. Hebbel R.P., Morgan W.T., Eaton J.W., Hedlund B.E. Accelerated autoxidation and heme loss due to instability of sickle hemoglobin. Proc. Natl. Acad. Sci. USA 1988, 85:237-241.
27. Hobbs M.R., Udhayakumar V., Levesque M.C., Booth J., Roberts J.M., Tkachuk A.N., Pole A., Coon H., Kariuki S., Nahlen B.L., et al. A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children. Lancet 2002, 360:1468-1475.
28. Hoffman R.A., Langrehr J.M., Billiar T.R., Curran R.D., Simmons R.L. Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine. J.Immunol. 1990, 145:2220-2226.
29. Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh Y., Oyake T., Hayashi N., Satoh K., Hatayama I., et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 1997, 236:313-322.
30. Itoh K., Wakabayashi N., Katoh Y., Ishii T., Igarashi K., Engel J.D., Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 1999, 13:76-86.
31. Jacobs T., Graefe S.E., Niknafs S., Gaworski I., Fleischer B. Murine malaria is exacerbated by CTLA-4 blockade. J.Immunol. 2002, 169:2323-2329.
32. Kensler T.W., Wakabayashi N., Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol. 2007, 47:89-116.
33. Larsen R., Gozzelino R., Jeney V., Tokaji L., Bozza F.A., Japiassú A.M., Bonaparte D., Cavalcante M.M., Chora A., Ferreira A., et al. A central role for free heme in the pathogenesis of severe sepsis. Sci. Transl. Med. 2010, 2:51ra71.
34. McDaid J., Yamashita K., Chora A., Ollinger R., Strom T.B., Li X.C., Bach F.H., Soares M.P. Heme oxygenase-1 modulates the allo-immune response by promoting activation-induced cell death of Tcells. FASEB J. 2005, 19:458-460.
35. Medzhitov R., Schneider D.S., Soares M.P. Disease tolerance as a defense strategy. Science 2012, 335:936-941.
36. Miller L.H., Ackerman H.C., Su X.Z., Wellems T.E. Malaria biology and disease pathogenesis: insights for new treatments. Nat. Med. 2013, 19:156-167.
37. Mishra S.K., Newton C.R. Diagnosis and management of the neurological complications of falciparum malaria. Nat Rev Neurol 2009, 5:189-198.
38. Miu J., Mitchell A.J., Müller M., Carter S.L., Manders P.M., McQuillan J.A., Saunders B.M., Ball H.J., Lu B., Campbell I.L., Hunt N.H. Chemokine gene expression during fatal murine cerebral malaria and protection due to CXCR3 deficiency. J.Immunol. 2008, 180:1217-1230.
39. Motterlini R., Foresti R., Intaglietta M., Winslow R.M. NO-mediated activation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium. Am. J. Physiol. 1996, 270:H107-H114.
40. Mustafa A.K., Gadalla M.M., Snyder S.H. Signaling by gasotransmitters. Sci. Signal. 2009, 2:re2.
41. Naughton P., Hoque M., Green C.J., Foresti R., Motterlini R. Interaction of heme with nitroxyl or nitric oxide amplifies heme oxygenase-1 induction: involvement of the transcription factor Nrf2. Cell. Mol. Biol. (Noisy-le-grand) 2002, 48:885-894.
42. Nitcheu J., Bonduelle O., Combadiere C., Tefit M., Seilhean D., Mazier D., Combadiere B. Perforin-dependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis. J.Immunol. 2003, 170:2221-2228.
43. Ong P.K., Melchior B., Martins Y.C., Hofer A., Orjuela-Sánchez P., Cabrales P., Zanini G.M., Frangos J.A., Carvalho L.J. Nitric oxide synthase dysfunction contributes to impaired cerebroarteriolar reactivity in experimental cerebral malaria. PLoS Pathog. 2013, 9:e1003444.
44. Pamplona A., Ferreira A., Balla J., Jeney V., Balla G., Epiphanio S., Chora A., Rodrigues C.D., Gregoire I.P., Cunha-Rodrigues M., et al. Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nat. Med. 2007, 13:703-710.
45. Patel R.P., Gladwin M.T. Physiologic, pathologic and therapeutic implications for hemoglobin interactions with nitric oxide. Free Radic. Biol. Med. 2004, 36:399-401.
46. Rother R.P., Bell L., Hillmen P., Gladwin M.T. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 2005, 293:1653-1662.
47. Sato K., Balla J., Otterbein L., Smith R.N., Brouard S., Lin Y., Csizmadia E., Sevigny J., Robson S.C., Vercellotti G., et al. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J.Immunol. 2001, 166:4185-4194.
48. Schneider D.S. Tracing personalized health curves during infections. PLoS Biol. 2011, 9:e1001158.
49. Schneider D.S., Ayres J.S. Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases. Nat. Rev. Immunol. 2008, 8:889-895.
50. Seixas E., Gozzelino R., Chora A., Ferreira A., Silva G., Larsen R., Rebelo S., Penido C., Smith N.R., Coutinho A., Soares M.P. Heme oxygenase-1 affords protection against noncerebral forms of severe malaria. Proc. Natl. Acad. Sci. USA 2009, 106:15837-15842.
51. Silva G., Jeney V., Chora A., Larsen R., Balla J., Soares M.P. Oxidized hemoglobin is an endogenous proinflammatory agonist that targets vascular endothelial cells. J.Biol. Chem. 2009, 284:29582-29595.
52. Soares M.P., Marguti I., Cunha A., Larsen R. Immunoregulatory effects of HO-1: how does it work?. Curr. Opin. Pharmacol. 2009, 9:482-489.
53. Spaccapelo R., Janse C.J., Caterbi S., Franke-Fayard B., Bonilla J.A., Syphard L.M., Di Cristina M., Dottorini T., Savarino A., Cassone A., et al. Plasmepsin 4-deficient Plasmodium berghei are virulence attenuated and induce protective immunity against experimental malaria. Am. J. Pathol. 2010, 176:205-217.
54. Suzuki T., Motohashi H., Yamamoto M. Toward clinical application of the Keap1-Nrf2 pathway. Trends Pharmacol. Sci. 2013, 34:340-346.
55. Taylor T.E., Fu W.J., Carr R.A., Whitten R.O., Mueller J.S., Fosiko N.G., Lewallen S., Liomba N.G., Molyneux M.E. Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat. Med. 2004, 10:143-145.
56. Tenhunen R., Marver H.S., Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc. Natl. Acad. Sci. USA 1968, 61:748-755.
57. Trovoada Mde.J., Martins M., Ben Mansour R., Sambo Mdo.R., Fernandes A.B., Antunes Gonçalves L., Borja A., Moya R., Almeida P., Costa J., et al. NOS2 variants reveal a dual genetic control of nitric oxide levels, susceptibility to Plasmodium infection, and cerebral malaria. Infect. Immun. 2014, 82:1287-1295.
58. Villegas-Mendez A., Greig R., Shaw T.N., de Souza J.B., Gwyer Findlay E., Stumhofer J.S., Hafalla J.C., Blount D.G., Hunter C.A., Riley E.M., Couper K.N. IFN-γ-producing CD4+ Tcells promote experimental cerebral malaria by modulating CD8+ Tcell accumulation within the brain. J.Immunol. 2012, 189:968-979.
59. Walther M., De Caul A., Aka P., Njie M., Amambua-Ngwa A., Walther B., Predazzi I.M., Cunnington A., Deininger S., Takem E.N., et al. HMOX1 gene promoter alleles and high HO-1 levels are associated with severe malaria in Gambian children. PLoS Pathog. 2012, 8:e1002579.
60. Weiss G., Werner-Felmayer G., Werner E.R., Grünewald K., Wachter H., Hentze M.W. Iron regulates nitric oxide synthase activity by controlling nuclear transcription. J.Exp. Med. 1994, 180:969-976.
61. Weiss G., Thuma P.E., Biemba G., Mabeza G., Werner E.R., Gordeuk V.R. Cerebrospinal fluid levels of biopterin, nitric oxide metabolites, and immune activation markers and the clinical course of human cerebral malaria. J.Infect. Dis. 1998, 177:1064-1068.
62. Yeo T.W., Lampah D.A., Rooslamiati I., Gitawati R., Tjitra E., Kenangalem E., Price R.N., Duffull S.B., Anstey N.M. A randomized pilot study of L-arginine infusion in severe falciparum malaria: preliminary safety, efficacy and pharmacokinetics. PLoS ONE 2013, 8:e69587.